239 related articles for article (PubMed ID: 32067818)
1. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus Strain Surveillance in Estonia After Introduction of Rotavirus Universal Mass Vaccination.
Kõivumägi K; Soeorg H; Toompere K; Kallas E; Jõegeda EL; Lass E; Huik K; Lutsar I;
Pediatr Infect Dis J; 2021 May; 40(5):489-494. PubMed ID: 33847298
[TBL] [Abstract][Full Text] [Related]
3. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.
Zlamy M; Kofler S; Orth D; Würzner R; Heinz-Erian P; Streng A; Prelog M
BMC Infect Dis; 2013 Mar; 13():112. PubMed ID: 23452879
[TBL] [Abstract][Full Text] [Related]
4. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
[TBL] [Abstract][Full Text] [Related]
5. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.
Hemming M; Räsänen S; Huhti L; Paloniemi M; Salminen M; Vesikari T
Eur J Pediatr; 2013 Jun; 172(6):739-46. PubMed ID: 23361964
[TBL] [Abstract][Full Text] [Related]
6. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.
Restivo V; Caracci F; Sannasardo CE; Scarpitta F; Vella C; Ventura G; Tramuto F; Costantino C
Acta Biomed; 2018 Oct; 89(3):437-442. PubMed ID: 30333453
[TBL] [Abstract][Full Text] [Related]
8. Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?
Hegazi MA; Sayed MH; Sindi HH; Bekhit OE; El-Deek BS; Alshoudri FMY; Noorelahi AK
Medicine (Baltimore); 2017 Apr; 96(15):e6574. PubMed ID: 28403085
[TBL] [Abstract][Full Text] [Related]
9. Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan.
Kobayashi M; Miyazaki M; Ogawa A; Tatsumi M
Hum Vaccin Immunother; 2020; 16(1):132-137. PubMed ID: 31298962
[TBL] [Abstract][Full Text] [Related]
10. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
[TBL] [Abstract][Full Text] [Related]
11. Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.
Wilson SE; Rosella LC; Wang J; Le Saux N; Crowcroft NS; Harris T; Bolotin S; Deeks SL
PLoS One; 2016; 11(5):e0154340. PubMed ID: 27168335
[TBL] [Abstract][Full Text] [Related]
12. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
Tafalla M; Gardovska D; Gopala K; Kozlovska L
Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
[No Abstract] [Full Text] [Related]
13. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
Banajeh SM; Abu-Asba BA
BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
[TBL] [Abstract][Full Text] [Related]
14. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
[TBL] [Abstract][Full Text] [Related]
15. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.
Ruiz-Contreras J; Alfayate-Miguelez S; Carazo-Gallego B; Onís E; Díaz-Munilla L; Mendizabal M; Méndez Hernández M; Ferrer-Lorente B; Unsaín-Mancisidor M; Ramos-Amador JT; Croche-Santander B; Centeno Malfaz F; Rodríguez-Suárez J; Cotarelo M; San-Martín M; Arístegui J
BMC Infect Dis; 2021 Nov; 21(1):1138. PubMed ID: 34742235
[TBL] [Abstract][Full Text] [Related]
17. Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan.
Oishi T; Hasegawa S; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Tamura T
Hum Vaccin Immunother; 2024 Dec; 20(1):2322202. PubMed ID: 38478958
[TBL] [Abstract][Full Text] [Related]
18. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
[TBL] [Abstract][Full Text] [Related]
19. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
[TBL] [Abstract][Full Text] [Related]
20. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016.
Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA
BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
